Cargando…

Factors Associated with Deworming Medication Utilization among Pregnant Women in Benin: Evidence from the Demographic and Health Survey

Deworming medication utilization is a useful strategy to reduce the burden of anemia among pregnant women. Yet, we know very little about the prevalence and correlates of deworming medication utilization among pregnant women in sub-Saharan Africa, including Benin. To address this void in the literat...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoak, Daniel, Dhillon, Satveer, Antabe, Roger, Sano, Yujiro, Luginaah, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053996/
https://www.ncbi.nlm.nih.gov/pubmed/36977167
http://dx.doi.org/10.3390/tropicalmed8030166
_version_ 1785015546592362496
author Amoak, Daniel
Dhillon, Satveer
Antabe, Roger
Sano, Yujiro
Luginaah, Isaac
author_facet Amoak, Daniel
Dhillon, Satveer
Antabe, Roger
Sano, Yujiro
Luginaah, Isaac
author_sort Amoak, Daniel
collection PubMed
description Deworming medication utilization is a useful strategy to reduce the burden of anemia among pregnant women. Yet, we know very little about the prevalence and correlates of deworming medication utilization among pregnant women in sub-Saharan Africa, including Benin. To address this void in the literature, we used the 2017–2018 Benin Demographic and Health Survey and applied logistic regression analysis to explore the demographic, socioeconomic, and healthcare factors associated with deworming medication utilization in Benin. We found that deworming medication coverage was 65% at the national level. We observed that women aged 35–49 years were less likely to use deworming medication compared to those aged 15–24 years (OR = 0.79, p < 0.01). Compared to Christian women, Muslim women (OR = 0.70, p < 0.01) and women of other religions (OR = 0.51, p < 0.01) were also less likely to use deworming medication. Moreover, women with lower levels of education and household wealth, as well as unemployed women, were less likely to use deworming medication in comparison to their educated, richer, and employed counterparts. Women who visited ANC fewer than eight times were also less likely to use deworming medication compared to their counterparts who did so eight times or more (OR = 0.65, p < 0.001). Based on these findings, we discussed several implications for policymakers.
format Online
Article
Text
id pubmed-10053996
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100539962023-03-30 Factors Associated with Deworming Medication Utilization among Pregnant Women in Benin: Evidence from the Demographic and Health Survey Amoak, Daniel Dhillon, Satveer Antabe, Roger Sano, Yujiro Luginaah, Isaac Trop Med Infect Dis Article Deworming medication utilization is a useful strategy to reduce the burden of anemia among pregnant women. Yet, we know very little about the prevalence and correlates of deworming medication utilization among pregnant women in sub-Saharan Africa, including Benin. To address this void in the literature, we used the 2017–2018 Benin Demographic and Health Survey and applied logistic regression analysis to explore the demographic, socioeconomic, and healthcare factors associated with deworming medication utilization in Benin. We found that deworming medication coverage was 65% at the national level. We observed that women aged 35–49 years were less likely to use deworming medication compared to those aged 15–24 years (OR = 0.79, p < 0.01). Compared to Christian women, Muslim women (OR = 0.70, p < 0.01) and women of other religions (OR = 0.51, p < 0.01) were also less likely to use deworming medication. Moreover, women with lower levels of education and household wealth, as well as unemployed women, were less likely to use deworming medication in comparison to their educated, richer, and employed counterparts. Women who visited ANC fewer than eight times were also less likely to use deworming medication compared to their counterparts who did so eight times or more (OR = 0.65, p < 0.001). Based on these findings, we discussed several implications for policymakers. MDPI 2023-03-12 /pmc/articles/PMC10053996/ /pubmed/36977167 http://dx.doi.org/10.3390/tropicalmed8030166 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Amoak, Daniel
Dhillon, Satveer
Antabe, Roger
Sano, Yujiro
Luginaah, Isaac
Factors Associated with Deworming Medication Utilization among Pregnant Women in Benin: Evidence from the Demographic and Health Survey
title Factors Associated with Deworming Medication Utilization among Pregnant Women in Benin: Evidence from the Demographic and Health Survey
title_full Factors Associated with Deworming Medication Utilization among Pregnant Women in Benin: Evidence from the Demographic and Health Survey
title_fullStr Factors Associated with Deworming Medication Utilization among Pregnant Women in Benin: Evidence from the Demographic and Health Survey
title_full_unstemmed Factors Associated with Deworming Medication Utilization among Pregnant Women in Benin: Evidence from the Demographic and Health Survey
title_short Factors Associated with Deworming Medication Utilization among Pregnant Women in Benin: Evidence from the Demographic and Health Survey
title_sort factors associated with deworming medication utilization among pregnant women in benin: evidence from the demographic and health survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053996/
https://www.ncbi.nlm.nih.gov/pubmed/36977167
http://dx.doi.org/10.3390/tropicalmed8030166
work_keys_str_mv AT amoakdaniel factorsassociatedwithdewormingmedicationutilizationamongpregnantwomeninbeninevidencefromthedemographicandhealthsurvey
AT dhillonsatveer factorsassociatedwithdewormingmedicationutilizationamongpregnantwomeninbeninevidencefromthedemographicandhealthsurvey
AT antaberoger factorsassociatedwithdewormingmedicationutilizationamongpregnantwomeninbeninevidencefromthedemographicandhealthsurvey
AT sanoyujiro factorsassociatedwithdewormingmedicationutilizationamongpregnantwomeninbeninevidencefromthedemographicandhealthsurvey
AT luginaahisaac factorsassociatedwithdewormingmedicationutilizationamongpregnantwomeninbeninevidencefromthedemographicandhealthsurvey